Enantioselective Antiviral Activities of Chiral Zinc Oxide Nanoparticles

Direct Readout of Homo- vs Heterochiral Ligand Shell of Quantum Dots

The chiroptical activity of various semiconductor inorganic nanocrystalline materials has typically been tested using circular dichroism or circularly polarized luminescence. Herein, we report on a high-throughput screening method for identifying and differentiating chiroptically active quantum-sized ZnO crystals using Raman spectroscopy combined with principal component analysis. ZnO quantum dots (QDs) coated by structurally diverse homo- and heterochiral aminoalcoholate ligands (cis- and trans-1-amino-2-indanolate, 2-amino-1-phenylethanolate, and diphenyl-2-pyrrolidinemethanolate) were prepared using the one-pot self-supporting organometallic procedure and then extensively studied toward the identification of specific Raman fingerprints and spectral variations. The direct comparison between the spectra demonstrates that it is very difficult to make definite recognition and identification between QDs coated with enantiomers based only on the differences in the respective Raman bands' position shifts and their intensities. However, the applied approach involving the principal component analysis performed on the Raman spectra allows the simultaneous differentiation and identification of the studied QDs. The first and second principal components explain 98, 97, 97, and 87% of the variability among the studied families of QDs and demonstrate the possibility of using the presented method as a qualitative assay. Thus, the reported multivariate approach paves the way for simultaneous differentiation and identification of chirotopically active semiconductor nanocrystals.

Stixis scandens leaf extract-loading ZnO nanoparticles for porcine epidemic diarrhea virus (PEDV) treatment

Porcine epidemic diarrhea (PED) is one of the diseases that causes great losses for livestock farmers. Because vaccines against the disease are not very effective, there is a great demand for biological products with effective resistance to PED virus (PEDV). One of the most important trends today is the use of active ingredients from nature in animal husbandry. This study aimed to create an effective agent against PEDV from the extract of Stixis scandens, which has been shown to inhibit PEDV. The aqueous (denoted as TCN) and ethanolic extracts (denoted as TCC) of Stixis scandens leaves were first prepared and then qualitatively analyzed for their chemical compositions. The TCN was used to synthesize ZnO nanoparticles (NPs) at various sizes from 20 to 120 nm. Subsequently, TCC was loaded on ZnO NPs to form ZnO-extract nanoformulations with an extract loading content of 5.8-7.6%. Total polyphenols (TP) and total alkaloids (TA) in TCC were 38.51 ± 0.25 μg GAE per mg and 22.37 ± 0.41 μg AtrE per mg, respectively. TP was less loaded but more released from the nanoformulations than TA. The A1T nanoformulation, containing only 7.6% extract, had a minimum PEDV inhibitory concentration of 3.9 μg mL-1, which was comparable to that of TCC. The experiments confirmed that the nanoformulations are promising for PEDV inhibition applications.

UiO-66 nanoparticles combat influenza A virus in mice by activating the RIG-I-like receptor signaling pathway

The Influenza A virus (IAV) is a zoonotic pathogen that infects humans and various animal species. Infection with IAV can cause fever, anorexia, and dyspnea and is often accompanied by pneumonia characterized by an excessive release of cytokines (i.e., cytokine storm). Nanodrug delivery systems and nanoparticles are a novel approach to address IAV infections. Herein, UiO-66 nanoparticles (NPs) are synthesized using a high-temperature melting reaction. The in vitro and in vivo optimal concentrations of UiO-66 NPs for antiviral activity are 200 μg mL-1 and 60 mg kg-1, respectively. Transcriptome analysis revealed that UiO-66 NPs can activate the RIG-I-like receptor signaling pathway, thereby enhancing the downstream type I interferon antiviral effect. These NPs suppress inflammation-related pathways, including the FOXO, HIF, and AMPK signaling pathways. The inhibitory effect of UiO-66 NPs on the adsorption and entry of IAV into A549 cells is significant. This study presents novel findings that demonstrate the effective inhibition of IAV adsorption and entry into cells via UiO-66 NPs and highlights their ability to activate the cellular RIG-I-like receptor signaling pathway, thereby exerting an anti-IAV effect in vitro or in mice. These results provide valuable insights into the mechanism of action of UiO-66 NPs against IAV and substantial data for advancing innovative antiviral nanomedicine.